Skip to content
lsd.com

Rhode Island

Psychedelic trials in Rhode Island

8 registered trials has a study site in Rhode Island, and 3 are recruiting now.

8
Trials with a site here
3
Recruiting
5
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454 · Janssen Research & Development, LLCRecruitingPhase 3ketamine35
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use DisorderNCT07118839 · VA Office of Research and DevelopmentRecruitingPhase 2 / Phase 3mdma2
MDMA for AUD/PTSD ComorbidityNCT05943665 · Carolina L Haass-KofflerRecruitingPhase 2mdma1

Facilities

Where the research happens in Rhode Island

FacilityCityTrials
Bradley HospitalEast Providence1
Providence VA Medical Center, Providence, RIProvidence1
Brown UniversityProvidence1
The Warren Alpert Medical School of Brown University - Butler HospitalProvidence1
The Miriam HospitalProvidence1

Stay told

When a trial opens in Rhode Island

Research alerts

Get a notification when a trial for trials in Rhode Island starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a Rhode Island site

TrialStatusPhaseSubstanceSites
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454 · Janssen Research & Development, LLCRecruitingPhase 3ketamine35
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use DisorderNCT07118839 · VA Office of Research and DevelopmentRecruitingPhase 2 / Phase 3mdma2
MDMA for AUD/PTSD ComorbidityNCT05943665 · Carolina L Haass-KofflerRecruitingPhase 2mdma1
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant DepressionNCT04599855 · Janssen Research & Development, LLCCompletedPhase 4ketamine54
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionNCT02417064 · Janssen Research & Development, LLCCompletedPhase 3ketamine90
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionNCT02493868 · Janssen Research & Development, LLCCompletedPhase 3ketamine155
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLCCompletedPhase 3ketamine173
Ketamine for Mood Disorders With Suicidal IdeationNCT04099771 · The Miriam HospitalUnknown statusEarly Phase 1ketamine1

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states